Becker, Winston R. http://orcid.org/0000-0001-7876-5060
Nevins, Stephanie A.
Chen, Derek C. http://orcid.org/0000-0001-9652-4885
Chiu, Roxanne
Horning, Aaron M. http://orcid.org/0000-0003-3247-0798
Guha, Tuhin K.
Laquindanum, Rozelle
Mills, Meredith
Chaib, Hassan
Ladabaum, Uri
Longacre, Teri
Shen, Jeanne http://orcid.org/0000-0002-1519-0308
Esplin, Edward D. http://orcid.org/0000-0001-9205-3756
Kundaje, Anshul http://orcid.org/0000-0003-3084-2287
Ford, James M.
Curtis, Christina
Snyder, Michael P. http://orcid.org/0000-0003-0784-7987
Greenleaf, William J. http://orcid.org/0000-0003-1409-3095
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U2C CA233311, U2C CA233311, U2C CA233311, U2C CA233311, U2C CA233311)
U.S. Department of Health & Human Services | National Institutes of Health (RM1-HG007735, UM1-HG009442, UM1-HG009436, R01- HG00990901, U19- AI057266, P30DK116074, S10OD025212)
Article History
Received: 11 May 2021
Accepted: 28 April 2022
First Online: 20 June 2022
Competing interests
: W.J.G. is a consultant and equity holder for 10x Genomics, Guardant Health, Quantapore and Ultima Genomics, and cofounder of Protillion Biosciences, and is named on patents describing ATAC-seq. M.P.S. is a cofounder and scientific advisor for Personalis, Qbio, January.ai, Filtricine, Mirvie and Protos, and an advisor for Genapsys. A.K. is a consultant with Illumina, Inc. The remaining authors declare no competing interests.